Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS44021745HTLV-1ENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS44014146HTLV-1ENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS44000462HTLV-1ENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS44021746HTLV-1ENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS44033264HTLV-1ENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS44037432HTLV-1ENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TCGA Plot Options
Drug Information
GeneCHRM3
DrugBank IDDB00376
Drug NameTrihexyphenidyl
Target IDBE0000045
UniProt IDP20309
Regulation Typeantagonist
PubMed IDs1635586; 1994002; 3208836
CitationsBognar IT, Altes U, Beinhauer C, Kessler I, Fuder H: A muscarinic receptor different from the M1, M2, M3 and M4 subtypes mediates the contraction of the rabbit iris sphincter. Naunyn Schmiedebergs Arch Pharmacol. 1992 Jun;345(6):611-8.@@Dorje F, Wess J, Lambrecht G, Tacke R, Mutschler E, Brann MR: Antagonist binding profiles of five cloned human muscarinic receptor subtypes. J Pharmacol Exp Ther. 1991 Feb;256(2):727-33.@@Freedman SB, Beer MS, Harley EA: Muscarinic M1, M2 receptor binding. Relationship with functional efficacy. Eur J Pharmacol. 1988 Oct 26;156(1):133-42.
GroupsApproved
Direct ClassificationAralkylamines
SMILESOC(CCN1CCCCC1)(C1CCCCC1)C1=CC=CC=C1
Pathways
PharmGKBPA164747026
ChEMBLCHEMBL1490